Back to Search
ANTHONY CORSO, MD
MD
Specialist
NPI: 1790847861IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
192350(NY)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.
PMID 19633044·Ann Oncol·2010
8-other
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.
PMID 19674790·Leuk Res·2010
3-trial
Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.
PMID 19375164·Leuk Res·2009
8-other
Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.
PMID 19018860·Eur J Haematol·2009
8-other
[Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005].
PMID 19531318·Rev Panam Salud Publica·2009
8-other
[Nutritional profile and factors associated with malnutrition in Kaingáng children on the Mangueirinha Indigenous Reserve, Paraná State, Brazil].
PMID 19219249·Cad Saude Publica·2009
8-other
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts.
PMID 19018865·Eur J Haematol·2009
8-other
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived.
PMID 19519727·Eur J Haematol·2009
8-other
Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae.
PMID 19386850·J Clin Microbiol·2009
8-other
A striking response to bortezomib in a patient with pleural localization of multiple myeloma.
PMID 18842298·Leuk Res·2009
5-case
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program.
PMID 19036114·Br J Haematol·2009
3-trial
Infiltration of the spinal cord in a patient with multiple myeloma.
PMID 18757337·J Clin Oncol·2008
5-case
Immune-mediated neuropathies in myeloma patients treated with bortezomib.
PMID 18829381·Clin Neurophysiol·2008
5-case
DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.
PMID 18248573·Transfusion·2008
3-trial
Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.
PMID 17997154·Leuk Res·2008
5-case
Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy.
PMID 18096226·Leuk Res·2008
8-other
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.
PMID 17664489·J Clin Oncol·2007
5-case
Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005.
PMID 17687007·J Clin Microbiol·2007
8-other
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
PMID 18032762·N Engl J Med·2007
3-trial
The impact of new emerging drugs in the treatment of multiple myeloma: is there still a role for PBSC transplantation?
PMID 18220887·Curr Stem Cell Res Ther·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 176 N VILLAGE AVE, SUITE 2D
ROCKVILLE CENTRE, NY 11570 - Phone
- (516) 764-2115
Quick Facts
- NPI
- 1790847861
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile